Denmark· DK-28107007123
Liglifev
A metformin and linagliptin product containing linagliptin, metforminhydrochlorid, registered in Denmark by Novalie Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Metformin and linagliptin is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BD11 (metformin and linagliptin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Metformin and linagliptin · ATC A10BD11
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Linagliptin, METFORMINHYDROCHLORID
- Manufacturer
- Novalie Pharma B.V.
- Country
- Denmark (DK)
- ATC code
- A10BD11
- ATC class
- Metformin and linagliptin
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107007123
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and linagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and linagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under A10BD11
Metformin and linagliptin, as other registers publish it.
- PolandAutnamiSandoz Polska Sp. z o.o.
- PolandAutnamiSandoz Polska Sp. z o.o.
- DenmarkGlymetiaPharmaPath S.A.
- DenmarkGlymetiaPharmaPath S.A.
- PolandJentaduetoBoehringer Ingelheim International GmbH
- United StatesJentaduetoBoehringer Ingelheim Pharmaceuticals, Inc.
- NorwayJentaduetoBoehringer Ingelheim International GmbH
- United StatesJentaduetoBoehringer Ingelheim Pharmaceuticals, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c64e6f58-2c78-43d0-8efa-014b6870c04e GET /v1/drugs/c64e6f58-2c78-43d0-8efa-014b6870c04e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "2,5+1000 mg",
"auth_role": "RMS",
"dk_drugid": "28107007123",
"substance": "Linagliptin, METFORMINHYDROCHLORID",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "45707"
}See everything about metformin and linagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.